Results 11 to 20 of about 2,994 (114)
Subacute cutaneous lupus erythematosus presenting as erythroderma
Indian Journal of Dermatology, 2014 Subacute cutaneous lupus erythematosus (SCLE) is a type of lupus erythematosus having distinct characteristic clinical, serologic, and genetic features. Other than the commonly occurring papulosquamous and annular polycyclic lesion, rarely it may present as erythema multiformae, toxic epidermo necrolysis like lesion (Rowell syndrome), erythroderma, and
RA Divyashree +5 more
openaire +4 more sources
Natural History of Idiosyncratic Drug‐Induced Liver Injury and Prognostic Models
Liver International, Volume 45, Issue 6, June 2025.ABSTRACT Background and Aims: Drug‐induced liver injury (DILI) remains a leading cause of acute liver failure worldwide. Drugs such as isoniazid, alone or in combination with other anti‐tuberculosis drugs, as well as a growing number of herbal and complementary medicines, have been implicated in most cases of acute liver failure in registry studies ...
Harshad C. Devarbhavi, Raúl J. Andrade
wiley +1 more source
Respirology Case Reports, Volume 13, Issue 4, April 2025.We present a case of diffuse cystic lung disease without any known underlying systemic disorder, biopsy confirmed as lymphoid interstitial pneumonia (LIP). This case highlights the benefit of histological confirmation where there is diagnostic uncertainty and the clinical situation permits, particularly in the setting of symptomatic deterioration ...
Han Xin Lau +3 more
wiley +1 more source
Experimental Dermatology, Volume 34, Issue 4, April 2025.ABSTRACT JAK inhibitors are used to treat various inflammatory skin diseases. However, systemic formulations are associated with an increased risk of major adverse events. Ruxolitinib 1.5% cream is a selective topical JAK1 and JAK2 inhibitor, which has recently been approved by EMA and MHRA for treating non‐segmental vitiligo, while being FDA‐approved ...
Marco Spadafora +5 more
wiley +1 more source
JEADV Clinical Practice, Volume 4, Issue 1, Page 207-215, March 2025.We treated 6 patients, suffering from SLE or DLE resistant to conventional treatments, with anifrolumab (monoclonal antibody that targets the type 1 interferon receptor subunit 1). The mean CLASI decreased by almost 60% at 1 to 2 months. The mean CLASI score at baseline was 14.2 ± 10.6 (median: 10.5) and decreased to 5.7 ± 5.3 (median: 3.0) after one ...
E. Parriel +7 more
wiley +1 more source
Outcomes of a fledgling public dermatology clinic in rural Australia
Australasian Journal of Dermatology, Volume 66, Issue 2, Page 93-96, March 2025.Abstract There is paucity of research available regarding the epidemiological characteristics of patients attending dermatology outpatient services in rural Australia. We performed a retrospective cohort study of patients attending a public dermatology clinic established at Dubbo Base Hospital in rural New South Wales. The broad range of dermatological
Grace Xiaoying Li +2 more
wiley +1 more source
Clinical Case Reports, Volume 13, Issue 2, February 2025.ABSTRACT The coexistence of systemic lupus erythematosus (SLE) and Wilson's disease (WD) is exceedingly rare, posing significant diagnostic challenges due to overlapping clinical presentations. Neurological and psychiatric manifestations commonly associated with WD can obscure or mimic symptoms of other systemic diseases, complicating accurate ...
Suresh Bhagoowani +6 more
wiley +1 more source
Health Science Reports, Volume 8, Issue 2, February 2025.ABSTRACT Background Rowell syndrome (RS), an infrequent illness characterized by a combination of erythema multiforme‐like manifestations and systemic lupus erythematosus, poses diagnostic and clinical issues to the healthcare system. Initially discovered by Dr.
Azadeh Khayyat +4 more
wiley +1 more source
Cutaneous reactions to vaccination
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 2, Page 195-209, February 2025.Summary Vaccination is a fundamental principle of preventive health care. Administration of the vaccine, which contains the antigen(s) of a pathogen, activates the immune system and provides protection against infection. The immunogenicity and allergenicity of a vaccine may lead to various adverse reactions, depending on the responsiveness and ...
Jacqueline Kussini +3 more
wiley +1 more source
Terbinafine-induced Subacute Cutaneous Lupus Erythematosus
Acta Dermato-Venereologica, 2004 Oral terbinafine is licensed for use in onychomycosis after positive confirmation of infection. We describe five cases of subacute cutaneous lupus erythematosus associated with terbinafine therapy. All cases had positive antibodies to extractable nuclear antigens, predominantly anti-Ro, and several had a history of pre-existing autoimmune disease ...
David A McKay +2 more
openaire +3 more sources